Page last updated: 2024-09-02

ramosetron and Breast Cancer

ramosetron has been researched along with Breast Cancer in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baek, SH; Baik, SW; Kim, CH; Kim, HK; Kim, KH; Kwon, JY; Lee, HJ; Shin, SW	1
Hojo, S; Noguchi, S; Shiba, E; Taguchi, T; Takamura, Y; Tsukamoto, F; Watanabe, T; Yoneda, K	1

Trials

2 trial(s) available for ramosetron and Breast Cancer

Article	Year
Preoperatively administered ramosetron oral disintegrating tablets for preventing nausea and vomiting associated with patient-controlled analgesia in breast cancer patients. European journal of anaesthesiology, 2008, Volume: 25, Issue:9 Topics: Administration, Oral; Adult; Analgesia, Patient-Controlled; Analgesics, Opioid; Antiemetics; Benzimidazoles; Breast Neoplasms; Female; Fentanyl; Humans; Middle Aged; Pain Measurement; Patient Satisfaction; Postoperative Nausea and Vomiting; Premedication; Serotonin Antagonists; Treatment Outcome	2008
[Usefulness of ramosetron hydrochloride on nausea and vomiting in CMF or CEF therapy for breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:8 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Appetite; Benzimidazoles; Breast Neoplasms; Breast Neoplasms, Male; Cisplatin; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Nausea; Safety; Serotonin Antagonists; Treatment Outcome; Vomiting	1999

Article

Year

Preoperatively administered ramosetron oral disintegrating tablets for preventing nausea and vomiting associated with patient-controlled analgesia in breast cancer patients.

European journal of anaesthesiology, 2008, Volume: 25, Issue:9

Topics: Administration, Oral; Adult; Analgesia, Patient-Controlled; Analgesics, Opioid; Antiemetics; Benzimidazoles; Breast Neoplasms; Female; Fentanyl; Humans; Middle Aged; Pain Measurement; Patient Satisfaction; Postoperative Nausea and Vomiting; Premedication; Serotonin Antagonists; Treatment Outcome

2008

[Usefulness of ramosetron hydrochloride on nausea and vomiting in CMF or CEF therapy for breast cancer].

Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:8

Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Appetite; Benzimidazoles; Breast Neoplasms; Breast Neoplasms, Male; Cisplatin; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Nausea; Safety; Serotonin Antagonists; Treatment Outcome; Vomiting

1999